The review also notes that GLP-1 medicines reduce complications in conditions such as obstructive sleep apnea (OSA), expanding their cardiometabolic relevance
GLP-1 peptides have the following functions: Stimulate insulin release Slow down the digestion of food Reduces the sugar your liver makes It makes you feel full and not hungry These medications are available as tablets and injections
Patients with specific genetic profiles often succeed with approaches that might not work for otherspersonalization prevents unnecessary nausea suffering
Nonetheless, GLP-1 medicines also exert anti-inflammatory effects independent of their metabolic effects
It deserves the same evidencebased, compassionate, chronicdisease management we apply to HIV, to hepatitis C, to diabetes
The active receptor targets are the same, but the formulation, source, and regulatory pathway differ